These results, along with a previous report showing that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 support the idea of targeting ACKR3 as a novel solution to modulate the opioid procedure, which could open new therapeutic avenues for opioid-similar Diseases. By ticking this box and submitting https://charliemrtog.blogs100.com/33047362/a-review-of-conolidine